Publications by authors named "Satyen Gohill"
This retrospective, observational study evaluated patterns of inpatient versus outpatient tumour lysis syndrome (TLS) monitoring during venetoclax ramp-up in 170 patients with chronic lymphocytic leukaemia. The primary outcome was clinical/biochemical TLS. Two clinical and four biochemical TLS occurred (4.
View Article and Find Full Text PDFArticle Synopsis
- - Elderly CLL patients (>75 years) experience more toxicity from ibrutinib compared to younger patients, but the safety of venetoclax in older patients is unclear.
- - This study analyzes safety and efficacy data from 342 CLL patients aged 75 and older versus those under 75, focusing on non-trial treatment settings.
- - Results indicate that venetoclax is equally effective and safe for elderly patients, many of whom have already been treated with ibrutinib and have limited treatment options.